Kite Pharma, Inc. Share-based Payment Arrangement, Accelerated Cost
Kite Pharma, Inc. reported Share-based Payment Arrangement, Accelerated Cost of $3.80 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2015-03-26
- Kite Pharma, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2014-06-30 was $3.80M, a 0.00% change year-over-year.
- Kite Pharma, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2013-06-30 was $3.80M.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month |
|---|---|
| 2014-06-30 | $3.80M 10-Q · filed 2014-11-14 |
| 2013-06-30 | $3.80M 10-K · filed 2015-03-26 |